switch to tirzepatide from semaglutide Why You Might Tolerate One Weight Loss Drug Better Than Another Switching from Semaglutide to Tirzepetide

Studies were excluded if they were duplicative, lacked sufficient data, were of limited relevance, or focused on non-diabetic renal diseases without metabolic assessment

For a deeper look at how sublingual peptide delivery works across different molecules, our sublingual peptides guide covers the science in detail

Similar content being viewed by others Introduction Amid the continuously increasing global incidence of diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a cornerstone in type 2 diabetes treatment, demonstrating remarkable efficacy in glycemic control and cardiovascular risk reduction [1, 2]

At 12 months post-index, 66% of dulaglutide prescriptions were for 1.5 mg, followed by 3.0 mg (16%) and 0.75 mg (13%)

Not an outlier group